FDA Import Refusal SCS-3430389-5/11/6 — JAGSEER SINGH
The FDA refused shipment SCS-3430389-5/11/6 from JAGSEER SINGH (India) on Apr 30, 2024. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Apr 30, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75